JP2011518816A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518816A5
JP2011518816A5 JP2011505583A JP2011505583A JP2011518816A5 JP 2011518816 A5 JP2011518816 A5 JP 2011518816A5 JP 2011505583 A JP2011505583 A JP 2011505583A JP 2011505583 A JP2011505583 A JP 2011505583A JP 2011518816 A5 JP2011518816 A5 JP 2011518816A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
optionally substituted
group
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011505583A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518816A (ja
Filing date
Publication date
Priority claimed from GBGB0807451.0A external-priority patent/GB0807451D0/en
Application filed filed Critical
Publication of JP2011518816A publication Critical patent/JP2011518816A/ja
Publication of JP2011518816A5 publication Critical patent/JP2011518816A5/ja
Withdrawn legal-status Critical Current

Links

JP2011505583A 2008-04-24 2009-04-23 Plkインヒビター Withdrawn JP2011518816A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0807451.0 2008-04-24
GBGB0807451.0A GB0807451D0 (en) 2008-04-24 2008-04-24 Inhibitors of PLK
PCT/GB2009/001019 WO2009130453A1 (en) 2008-04-24 2009-04-23 Inhibitors of plk

Publications (2)

Publication Number Publication Date
JP2011518816A JP2011518816A (ja) 2011-06-30
JP2011518816A5 true JP2011518816A5 (cg-RX-API-DMAC7.html) 2012-05-31

Family

ID=39494145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505583A Withdrawn JP2011518816A (ja) 2008-04-24 2009-04-23 Plkインヒビター

Country Status (5)

Country Link
US (1) US20110190306A1 (cg-RX-API-DMAC7.html)
EP (1) EP2296662A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011518816A (cg-RX-API-DMAC7.html)
GB (1) GB0807451D0 (cg-RX-API-DMAC7.html)
WO (1) WO2009130453A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0803747D0 (en) * 2008-02-29 2008-04-09 Martin Enzyme and receptor modulation
GB0903480D0 (en) 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors
EP2516441B1 (en) * 2009-12-23 2015-01-21 Elan Pharmaceuticals Inc. Pteridinones as inhibitors of polo-like kinase
GB201211310D0 (en) 2012-06-26 2012-08-08 Chroma Therapeutics Ltd CSF-1R kinase inhibitors
BR112015008167B1 (pt) 2012-10-17 2020-11-17 Macrophage Pharma Limited composto, composição farmacêutica, métodos para a inibição da atividade de uma enzima quinase map p38, para o tratamento ou a prevenção de doença autoimune ou inflamatória em um indivíduo, e para o tratamento, a melhoria ou a redução da incidência de doença proliferativa de células em um indivíduo, uso de composto, e, ácido
JP6815318B2 (ja) * 2014-12-23 2021-01-20 ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド 二官能性分子によって標的化タンパク質分解を誘導する方法
GB201713975D0 (en) 2017-08-31 2017-10-18 Macrophage Pharma Ltd Medical use
AU2024265078A1 (en) 2023-05-04 2025-12-11 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder
US20250049810A1 (en) 2023-08-07 2025-02-13 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
US20250154171A1 (en) 2023-10-12 2025-05-15 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
WO2025255438A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578560A1 (en) * 2004-08-27 2006-03-02 Boehringer Ingelheim International Gmbh Dihydropteridinones, method for the production thereof, and use thereof as a medicament
MX2009004244A (es) * 2006-10-25 2009-05-14 Chroma Therapeutics Ltd Derivados de pteridina como inhibidores de cinasa tipo polo utiles en el tratamiento de cancer.

Similar Documents

Publication Publication Date Title
JP2011518816A5 (cg-RX-API-DMAC7.html)
JP2010507639A5 (cg-RX-API-DMAC7.html)
JP2010505802A5 (cg-RX-API-DMAC7.html)
JP2011513305A5 (cg-RX-API-DMAC7.html)
JP2008540389A5 (cg-RX-API-DMAC7.html)
RU97118591A (ru) Производные ацетамида, способ его получения и содержащие его фармацевтические композиции
JP2011527334A5 (cg-RX-API-DMAC7.html)
JP2012523457A5 (cg-RX-API-DMAC7.html)
JP2008509166A5 (cg-RX-API-DMAC7.html)
RU2008136072A (ru) Производные бензамидов и гетероаренов
FI946003A0 (fi) beta3-agonisteina käyttökelpoisia katekoliamiinisurrogaatteja
RU2018107227A (ru) Терапевтические и профилактические антибактериальные средства
RU2006147267A (ru) Конденсированное гетероциклическое соединение
RU2012123154A (ru) Способы лечения синдрома фибромиалгии
RU2012155118A (ru) Способы лечения биполярного расстройства
RU2006137079A (ru) Производные а-аминоамида, полезные при лечении синдрома усталых ног и вызывающих привыкание расстройств
RU2005133994A (ru) Оксимные производные и их применение в качестве фармацевтически активных агентов
JP2013533253A5 (cg-RX-API-DMAC7.html)
JP2012508249A5 (cg-RX-API-DMAC7.html)
JP2010508336A5 (cg-RX-API-DMAC7.html)
JP2013542980A5 (cg-RX-API-DMAC7.html)
JP2014500265A5 (cg-RX-API-DMAC7.html)
RU2013130256A (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
JP2006515613A5 (cg-RX-API-DMAC7.html)
CA2505029A1 (en) Isoindoline derivatives